معرفی
Karel Allegaert is a Researcher in the Pharmacy department at Erasmus MC with an extensive publication record of 593 research outputs. His work focuses on clinical pharmacology with specialization in neonatal and pediatric populations, making significant contributions to evidence-based medication practices for vulnerable patient groups.
His research expertise spans several critical areas:
- Pharmacokinetics and pharmacodynamics in special populations
- Neonatal pain management and analgesic efficacy
- Pharmacotherapy for premature infants
- Congenital conditions including diaphragm hernia
- Comparative clinical pharmacology across age groups from pediatrics to geriatrics
Dr. Allegaert's recent publications demonstrate methodological diversity including systematic reviews, cohort studies, and innovative applications of machine learning in neonatal care. His work bridges clinical practice and pharmaceutical science, with particular attention to medication safety and dosing in neonates and infants where evidence is often limited.
He actively participates in international research collaborations including the Co-OPT Collaboration and the INC Pain Working Group, demonstrating engagement with global research networks in his field. His fingerprint analysis shows strong contributions to pharmacokinetics (100%), neonatology (36%), paracetamol pharmacology (25%), and related specialty areas.